Articles published by AstraZeneca
New data show FARXIGA significantly lowers the risk of cardiovascular death in patients with heart failure
August 27, 2022
From AstraZeneca
Via Business Wire
Tickers
AZN
AstraZeneca aims to transform cancer outcomes with new data across industry-leading portfolio at ESMO 2022
August 24, 2022
From AstraZeneca
Via Business Wire
Tickers
AZN
CALQUENCE® (acalabrutinib) tablet formulation approved in the US across current indications
August 05, 2022
From AstraZeneca
Via Business Wire
Tickers
AZN
ULTOMIRIS® (ravulizumab-cwvz) Approved in the US for Adults with Generalized Myasthenia Gravis
April 28, 2022
From AstraZeneca
Via Business Wire
Tickers
AZN
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.